RPL17 and hepatocellular carcinoma: A study pointed out that the tumor-infiltrating effector CD8+ T cells showed a drastic increase in PD-1 expression, and PD-1 upregulation promoted CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients (10).